BRIEF-VIPC Signs MoU With Astrazeneca, Eli Lilly, Merck
Reuters
Nov 21
BRIEF-VIPC Signs MoU With Astrazeneca, Eli Lilly, Merck
Nov 20 (Reuters) - Virginia Innovation Partnership Corporation (VIPC):
VIPC SIGNS MOU WITH ASTRAZENECA, ELI LILLY, MERCK TO DEVELOP THE VIRGINIA CENTER FOR ADVANCED PHARMACEUTICAL MANUFACTURING TO TRAIN WORKFORCE OF THE FUTURE
VIPC: PARTNERSHIP COMMITS $120 MILLION OF WORKFORCE INVESTMENT FROM ASTRAZENECA, LILLY, AND MERCK
Source text: ID:nPn51cDH4a
Further company coverage: AZN.L
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.